The development of phenothiazines used to treat psychotic states, and later of long-acting injectable forms, is discussed. Considerations affecting the clinical use of these drugs, including patient compliance and relapse, are reviewed briefly. The depot neuroleptics appear particularly useful for noncompliant, forgetful, and treatment-resistant patients.